TRIM28 is often overexpressed in cancer [64]; however, its expression has been shown to be predictive of tumor class in human glioblastomas [65], and positively correlated with tumor size and development stage, whilst being negatively correlated with patient survival in human hepatocellular carcinoma [66]. The gene discussed is TRIM28; the disease is hepatocellular carcinoma.